U.S. Transportation Stock News

Why Pitney Bowes raised its 2026 revenue outlook Pitney Bowes (PBI) recently raised its full year 2026 revenue guidance to a range of US$1,800 million to US$1,860 million, up from a prior range that started at US$1,760 million. This adjustment, together with recent upward earnings estimate revisions and the absence of downward changes, has put fresh attention on how the stock’s current valuation lines up with those higher expectations. See our latest analysis for Pitney Bowes. The raised 2026...

Neurocrine Biosciences (NBIX) is back in focus after new two year Phase 3 CAHtalyst Adult data for CRENESSITY in classic congenital adrenal hyperplasia, highlighting sustained glucocorticoid reductions and a clean safety profile. See our latest analysis for Neurocrine Biosciences. At a share price of $127.68, Neurocrine Biosciences has seen a 1 year total shareholder return of 19.63%, while its year to date share price return of 9.19% points to fading short term momentum following recent...

PennyMac Mortgage Investment Trust (PMT) is back in focus after partnering with PennyMac Financial Services on the new Welcome Home: Athlete Mortgage Program for Team USA athletes, spotlighting its role in specialized residential mortgage financing. See our latest analysis for PennyMac Mortgage Investment Trust. While the Welcome Home program has put PennyMac Mortgage Investment Trust back on investors’ radar, the share price at US$12.12 reflects mixed momentum, with a 30 day share price...

What PROG Holdings' Recent Share Performance Tells You With no single headline event driving PROG Holdings (PRG) today, attention turns to how the stock has been trading recently and how that lines up with the company’s current fundamentals. See our latest analysis for PROG Holdings. Recent trading has been mixed, with a 10.24% 1 month share price return alongside a 5.73% 3 month share price decline, while the 1 year total shareholder return of 24.45% points to stronger longer term...

BlackLine (BL) has drawn investor attention after a sharp share price pullback, with the stock down about 15% over the past month and roughly 44% over the past 3 months. See our latest analysis for BlackLine. At a share price of $30.64, BlackLine’s recent 30 day share price return of 15% decline and 90 day share price return of 43.8% decline contrast with a 1 year total shareholder return of 35.1% decline. This pattern suggests momentum has been fading and risk perceptions may have...

If you are wondering whether Kinsale Capital Group at around US$345 per share looks like value or a value trap, the next sections break down what the current price might be implying. The stock has been volatile recently, with a 4.4% decline over the last 7 days, a 5.4% gain over 30 days, and returns of 12.1% decline year to date and 17.7% decline over the last year, set against 6.1% and 100.1% gains over 3 and 5 years respectively. Recent coverage around Kinsale Capital Group has focused on...

HF Sinclair recently saw analysts lift their consensus earnings estimate for the March 2026 quarter, anticipating higher year-over-year earnings and revenue, although the report itself now sits in the past relative to today’s date of 27 April 2026. Yet the fact that the Most Accurate Estimate now trails the higher consensus points to a growing split in analyst conviction around HF Sinclair’s near-term profitability. With this backdrop of sharply revised earnings expectations and emerging...

In April 2026, AnaptysBio announced that the Delaware Chancery Court dismissed Tesaro’s anticipatory breach of contract claim, rejecting Tesaro’s bid to cut Jemperli royalties and affirming that AnaptysBio had not repudiated their Collaboration and Exclusive License Agreement. The ruling removes a key legal challenge to AnaptysBio’s royalty stream while clearing the way for a July 2026 trial on AnaptysBio’s allegations that Tesaro and GSK materially breached the collaboration, including...

In April 2026, Erasca, Inc. announced it had narrowed the anticipated Phase 1 monotherapy data readout window for its pan-RAS molecular glue ERAS-0015 from the AURORAS-1 and JYP0015M101 trials to no later than mid-May 2026, from prior guidance of the first half of 2026. This tighter timeline highlights ERAS-0015’s importance within Erasca’s pipeline, as earlier-than-expected visibility on clinical data can influence how investors assess the company’s development progress and clinical risk...

Agree Realty (ADC) has drawn fresh attention after reporting first quarter 2026 results with year over year growth in core FFO and AFFO per share, while also completing its largest acquisition volume since 2022. See our latest analysis for Agree Realty. Despite the recent flurry of capital raises and acquisitions, Agree Realty’s share price has been steady overall, with a 30 day share price return of 3.06% and a 90 day share price return of 5.56%. The 5 year total shareholder return of 34.45%...

PennyMac Financial Services, Inc. and PennyMac Mortgage Investment Trust recently launched the “Welcome Home: Athlete Mortgage Program” with the U.S. Olympic & Paralympic Committee, offering Team USA athletes dedicated lending support, exclusive mortgage benefits, and tailored educational resources across the homeownership lifecycle. This initiative highlights how PennyMac is using high-profile national partnerships to reach a distinct borrower segment while deepening its brand awareness in...

Earlier this month, Microchip Technology introduced its MD-990-0011-B plug-in timing modules, co-developed with Intel, to provide turnkey, high-precision synchronization for Intel Xeon 6–based data center servers and 5G vRAN infrastructure, alongside multiple embedded controller and security-focused product launches and a new authorized distribution agreement with Spirit Electronics. Together, these initiatives show Microchip pushing deeper into AI data center timing, secure edge control,...

Pegasystems Inc. reported past first-quarter 2026 results with revenue of US$429.97 million and net income of US$32.76 million, both down from the prior year. The quarter underscored a contrast between weaker term license revenue and growing Pega Cloud momentum, as management emphasized ROI-driven AI adoption and heavier shareholder returns. We’ll now examine how this softer quarter, especially the shortfall in term license revenue, may reshape Pegasystems’ existing investment...

In March 2026, Viatris Inc voluntarily initiated a US nationwide Class II recall of a specific lot of Xanax XR (3 mg extended-release alprazolam tablets) after the product failed dissolution specifications, with the recall now ongoing under an FDA enforcement report. This targeted recall of a branded anxiety treatment raises questions about Viatris’ quality control processes and potential regulatory and reputational implications within its broader drug portfolio. We’ll now examine how this...

Crown Holdings has announced plans to build a new beverage can manufacturing facility in Northern India, expected to start operations in the second half of 2027 with capacity of about 2.20 billion cans a year to serve growing demand for aluminum packaging across alcoholic and non-alcoholic drinks. The project, backed by long-term customer commitments including United Breweries Limited and designed around advanced, sustainability-focused manufacturing standards, marks Crown’s entry into India...

Recent performance context for First Commonwealth Financial With no single headline event driving attention today, First Commonwealth Financial (FCF) is drawing interest as investors weigh its recent share performance alongside the bank’s latest reported financial metrics and business mix. See our latest analysis for First Commonwealth Financial. The recent 7.9% one month share price return and 11.0% year to date share price return at around $18.62 sit alongside a 1 year total shareholder...

AngloGold Ashanti (NYSE:AU) is in focus after AngloGold Ashanti Holdings plc reported early results from capped cash tender offers to buy back up to $650,000,000 of its outstanding 2028, 2030, and 2040 notes. See our latest analysis for AngloGold Ashanti. The tender offer update comes as AngloGold Ashanti’s share price sits at US$99.30, with a 1 month share price return of 11.36% and a year to date share price return of 16.00%. The 1 year total shareholder return of 162.17% and 5 year total...

Earnings turnaround and mixed market reaction Flagstar Bank National Association (FLG) returned to profitability in the first quarter of 2026, supported by disciplined expense management, net interest margin expansion, and healthier credit metrics, even as revenue came in below market expectations. See our latest analysis for Flagstar Bank National Association. At a share price of US$14.03, the stock has a 1 day share price return of a 2.23% decline and a 7 day share price return of a 4.23%...

Recent share performance and business snapshot Universal Technical Institute (UTI) has recently drawn investor attention after a period of mixed share performance, with declines over the past week and month alongside a positive move in the past 3 months and solid year to date gains. The company operates two segments: UTI and Concorde. It provides transportation, skilled trades, and healthcare education programs across the United States, and reports annual revenue of US$855.031 million and net...

Structure Therapeutics (GPCR) has drawn fresh attention after recent trading left the stock at US$45.49, while performance over the past 3 months and the past month contrasts sharply with a strong 1 year total return. See our latest analysis for Structure Therapeutics. The recent share price pullback, including a 3.25% one day share price decline and a 49.21% 90 day share price decline from a much stronger 1 year total shareholder return of 91.62%, suggests momentum has cooled as investors...

Intapp (INTA) recently extended its collaboration with DCM Insights, embedding DCM’s Activator research more deeply into the Intapp Celeste AI platform to support behavior driven business development for professional and financial services firms. See our latest analysis for Intapp. The partnership news comes as Intapp’s share price sits at $22.25, with a 1 day share price return of 2.44%, a 90 day share price return of 43.31%, and a 1 year total shareholder return of 59.08%. If this kind of...

How Farmers National Banc (FMNB) Has Been Trading Recently Farmers National Banc (FMNB) has been quietly posting mixed short term moves, with a 0.9% gain over the past month and a 4.1% return over the past 3 months, while one day and weekly moves remain relatively muted. See our latest analysis for Farmers National Banc. At a share price of $14.06, Farmers National Banc shows building momentum, with a 9.2% 1 month share price return and a 13.0% 1 year total shareholder return compared with a...

Why Old Second Bancorp is on investors’ radar today Old Second Bancorp (OSBC) is drawing attention after recent trading left the shares at $20.00, with performance over the past week, month, and past 3 months offering a mixed picture for bank investors. See our latest analysis for Old Second Bancorp. The recent 7 day share price return of an 8.8% decline contrasts with a 1 year total shareholder return of 29.84%. This suggests that short term momentum has cooled while longer term holders have...

In April 2026, First Hawaiian, Inc.’s board declared a quarterly cash dividend of US$0.26 per share, alongside reporting first-quarter net interest income of US$167.53 million and net income of US$67.78 million, both higher than a year earlier. The bank’s first-quarter report also showed earnings per share of US$0.55 and steady net charge-offs at 0.14% of average loans and leases, underscoring resilient credit quality. We’ll now examine how First Hawaiian’s earnings beat, tempered by a...